Interview with Odnir Finotti, Executive President, Pró Genéricos
When we last interviewed you in 2007, you said, “The generics business is a very exciting one,” but you “regret[ted] that the Government is not doing enough work to promote…
Address: Av. Morumbi, 8264 – Brooklin CEP 04703-002 – São Paulo, SP,Brazil
Tel: (11) 2144-6911
Eli Lilly and Company, Lilly or simply, as it is known that the pharmaceutical industry of North America, has 134 years of existence. The company, with global operations and one of the largest funds applied research and development, is today one of the largest biotech companies in the world and owns brands that have become synonymous with ancient relief for diseases such as Prozac and Zyprexa Cialis, and prefers to characterized as a company that sells innovation in physical and mental health through medications that are usually the pioneers and most advanced in their therapeutic classes.
In Brazil, the company participates in the construction of the pharmaceutical market 66 years ago, and is one of the most important industries in the country, one of the leaders in the areas of mental health, oncology and women’s health.
Humulin, Humatrope, Humalog, Prozac, Gemzar , ReoPro, of Zyprexa, Evista, Xigris, of Cialis, Fort, Cymbalta and Byetta
When we last interviewed you in 2007, you said, “The generics business is a very exciting one,” but you “regret[ted] that the Government is not doing enough work to promote…
As I was doing research on your company, GC-2, I was unable to find a lot of information since it is a rather new company. Could you bring me up…
In a past interview, you said that Ipsen is different than the “Big Pharmas” who have entered Brazil by acquisition. You’ve taken a different tack since arriving as one of…
There is little publicly available information on your personal history and the founding of Meizler. Can you share that story for our readers? Everybody has a story – unless they’re…
Diabetes affects an estimated 6 million Brazilians, a figure which is expected to double by 2025, in line with many other developing nations. Like many other “rich-country” diseases, there is…
When we interviewed you four years ago, you gave us a picture of the industry. How has that picture changed since then? We can start with the regulatory picture. In…
Hypermarcas is a huge, diversified corporation that sells everything from shampoo, to medicine. Would you consider it more of a consumer goods company that happens to sell pharmaceuticals, or the…
Many readers may find it counterintuitive that SINDUSFARMA, which represents syndicates, is organized by a team of management executives. Historically, these two groups tend to be in opposition. Can you…
What would you recommend in terms of increasing the competitiveness and growth of the Brazilian pharmaceutical industry? The Brazilian pharmaceutical industry needs to improve its R&D capabilities. I personally think…
We know the raw data already in the Brazilian market and the number changes since our last visit in 2007 – but how would you interpret these changes into a…
Minister Pimentel recently released the BrasilMaior plan, whose slogan is “Innovate to compete. Compete to grow.” How would you recommend the government innovate, compete, and grow in the pharmaceutical industry…
You’ve made some bold moves in your career – from the head of vaccines in Latin America, followed by stints in Colombia, Puerto Rico, and finally Brazil. What brought you…
See our Cookie Privacy Policy Here
